BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

626 related articles for article (PubMed ID: 28816643)

  • 1. Pharmacometabolomics Informs Quantitative Radiomics for Glioblastoma Diagnostic Innovation.
    Katsila T; Matsoukas MT; Patrinos GP; Kardamakis D
    OMICS; 2017 Aug; 21(8):429-439. PubMed ID: 28816643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biobanking: An Important Resource for Precision Medicine in Glioblastoma.
    Tan SY; Sandanaraj E; Tang C; Ang BT
    Adv Exp Med Biol; 2016; 951():47-56. PubMed ID: 27837553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomics enables precision medicine: "A White Paper, Community Perspective".
    Beger RD; Dunn W; Schmidt MA; Gross SS; Kirwan JA; Cascante M; Brennan L; Wishart DS; Oresic M; Hankemeier T; Broadhurst DI; Lane AN; Suhre K; Kastenmüller G; Sumner SJ; Thiele I; Fiehn O; Kaddurah-Daouk R;
    Metabolomics; 2016; 12(10):149. PubMed ID: 27642271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic variations in cancer patients with liver dysfunction: applications and challenges of pharmacometabolomics.
    Aboel Dahab A; El-Hag D; Moutamed GM; Aboel Dahab S; Abuknesha R; Smith NW
    Cancer Chemother Pharmacol; 2016 Sep; 78(3):465-89. PubMed ID: 27061417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomics in pharmacology - a delve into the novel field of pharmacometabolomics.
    Mussap M; Loddo C; Fanni C; Fanos V
    Expert Rev Clin Pharmacol; 2020 Feb; 13(2):115-134. PubMed ID: 31958027
    [No Abstract]   [Full Text] [Related]  

  • 6. Omics-Based Strategies in Precision Medicine: Toward a Paradigm Shift in Inborn Errors of Metabolism Investigations.
    Tebani A; Afonso C; Marret S; Bekri S
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systems Biology Approaches to Decipher the Underlying Molecular Mechanisms of Glioblastoma Multiforme.
    Kaynar A; Altay O; Li X; Zhang C; Turkez H; Uhlén M; Shoaie S; Mardinoglu A
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacometabolomics-aided Pharmacogenomics in Autoimmune Disease.
    Katsila T; Konstantinou E; Lavda I; Malakis H; Papantoni I; Skondra L; Patrinos GP
    EBioMedicine; 2016 Mar; 5():40-5. PubMed ID: 27077110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomic Signatures for Drug Response Phenotypes: Pharmacometabolomics Enables Precision Medicine.
    Kaddurah-Daouk R; Weinshilboum R;
    Clin Pharmacol Ther; 2015 Jul; 98(1):71-5. PubMed ID: 25871646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive profile of recurrent glioblastoma.
    Campos B; Olsen LR; Urup T; Poulsen HS
    Oncogene; 2016 Nov; 35(45):5819-5825. PubMed ID: 27041580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiomics: the bridge between medical imaging and personalized medicine.
    Lambin P; Leijenaar RTH; Deist TM; Peerlings J; de Jong EEC; van Timmeren J; Sanduleanu S; Larue RTHM; Even AJG; Jochems A; van Wijk Y; Woodruff H; van Soest J; Lustberg T; Roelofs E; van Elmpt W; Dekker A; Mottaghy FM; Wildberger JE; Walsh S
    Nat Rev Clin Oncol; 2017 Dec; 14(12):749-762. PubMed ID: 28975929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacometabonomics in humans: a new tool for personalized medicine.
    Everett JR
    Pharmacogenomics; 2015; 16(7):737-54. PubMed ID: 25929853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiomic Phenotyping in Brain Cancer to Unravel Hidden Information in Medical Images.
    Abrol S; Kotrotsou A; Salem A; Zinn PO; Colen RR
    Top Magn Reson Imaging; 2017 Feb; 26(1):43-53. PubMed ID: 28079714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI study identifies three subtypes of glioblastoma.
    Brower V
    Lancet Oncol; 2015 Oct; 16(13):e484. PubMed ID: 26365415
    [No Abstract]   [Full Text] [Related]  

  • 15. Medical Imaging Informatics.
    Hsu W; El-Saden S; Taira RK
    Adv Exp Med Biol; 2016; 939():167-224. PubMed ID: 27807748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacometabolomics-Based Translational Biomarkers: How to Navigate the Data Ocean.
    Bafiti V; Katsila T
    OMICS; 2022 Oct; 26(10):542-551. PubMed ID: 36149303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precision Medicine and Targeted Therapies in Breast Cancer.
    Greenwalt I; Zaza N; Das S; Li BD
    Surg Oncol Clin N Am; 2020 Jan; 29(1):51-62. PubMed ID: 31757313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omics sciences and precision medicine in glioblastoma.
    Micheletti C; Bonetti G; Madeo G; Gadler M; Benedetti S; Guerri G; Cristofoli F; Generali D; Donofrio CA; Cominetti M; Fioravanti A; Riccio L; Manganotti P; Caruso P; Bernini A; Fulcheri E; Stuppia L; Gatta V; Cecchin S; Marceddu G; Bertelli M
    Clin Ter; 2023; 174(Suppl 2(6)):77-84. PubMed ID: 37994751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacometabonomics: The Prediction of Drug Effects Using Metabolic Profiling.
    Everett JR
    Handb Exp Pharmacol; 2019; 260():263-299. PubMed ID: 31823071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introduction: Cancer Gene Networks.
    Clarke R
    Methods Mol Biol; 2017; 1513():1-9. PubMed ID: 27807826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.